Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Hata

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
International Journal of Systematic and Evolutionary Microbiology|June 9, 2009
Mycobacterium kyorinense sp. nov., a novel, slow-growing species, related to Mycobacterium celatum, isolated from human clinical specimensMitsuhiro Okazaki, Kiyofumi Ohkusu, Hiroyuki Hata, et al.
European Journal of Haematology|July 28, 2007
Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myelomaHirokazu Murakami, Hiroshi Handa, Masahiro Abe, et al.
Cell Reports|October 17, 2019
The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq ApproachHiroo Katsuya, Saiful Islam, Benjy Jek Yang Tan, et al.
Hematological Oncology|September 4, 2018
Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myelomaTetsuhiro Kasamatsu, Shuji Ozaki, Takayuki Saitoh, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
International Journal of Systematic and Evolutionary Microbiology|June 9, 2009
Mycobacterium kyorinense sp. nov., a novel, slow-growing species, related to Mycobacterium celatum, isolated from human clinical specimensMitsuhiro Okazaki, Kiyofumi Ohkusu, Hiroyuki Hata, et al.
European Journal of Haematology|July 28, 2007
Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myelomaHirokazu Murakami, Hiroshi Handa, Masahiro Abe, et al.
Cell Reports|October 17, 2019
The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq ApproachHiroo Katsuya, Saiful Islam, Benjy Jek Yang Tan, et al.
Hematological Oncology|September 4, 2018
Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myelomaTetsuhiro Kasamatsu, Shuji Ozaki, Takayuki Saitoh, et al.
Pageof 7